Phages and their application against drug‐resistant bacteria

At the beginning of the 20th century the phenomenon of spontaneous bacterial lysis was discovered independently by Twort and d'Herelle. Despite the suggestion at that time by d'Herelle that these agents might be applied to the control of bacterial diseases in the west this idea was explored in a desultory fashion only and was eventually discarded largely due to the advent of extensive antibiotic usage. However, interest was maintained in countries of the former Soviet Union where bacteriophage therapy has been applied extensively since that time. Central to this work was the Eliava Institute of Bacteriophage, Microbiology and Virology in Tbilisi, Georgia, which was founded in 1923 through the joint efforts of d'Herelle and the Georgian George Eliava. Ironically, given his contributions to public health in the Soviet Union, Eliava was branded as an enemy ofthe people in 1937 and executed, d'Herelle never again returned to Georgia. In spite of these tragic events this institute remained the focus for phage therapy in the world and despite being continuously active in this field for 75 years, now struggles for its financial life. In the Eliava Institute, phages were sought for bacterial pathogens implicated in disease outbreaks in different parts of the Soviet Union and were dispatched for use in hospitals throughout the country. Although infections caused by a wide variety of bacterial pathogens have been treated, much of this has been published in Russian and is not readily available in the west. Work has also been carried out in Poland over many years and this has only recently been published in English. By contrast, interest in the west has been limited to a small number of enthusiasts and academics and until very recently little interest has been shown. The main reason that the medical and scientific communities are now beginning to take notice, is the continuing world-wide rise in the incidence of multiply-antibiotic-resistant bacterial pathogens and the absence of effective means for their control. Recent publicity over the work of the Eliava Institute has concentrated the minds of the western world on the potential for infectious disease control that bacteriophage offer, a procedure that is biologically more acceptable than antibiotic use and which has been in use for several decades already.

[1]  J. Probst Antisense oligodeoxynucleotide and ribozyme design. , 2000, Methods.

[2]  I. Asheshov,et al.  The Effect of an Anti-Vi Bacteriophage on Typhoid Infection in Mice. , 1937 .

[3]  S. D. Elek STAPHYLOCOCCUS PYOGENES AND ITS RELATION TO DISEASE , 1959 .

[4]  E. Lowbury,et al.  The acquired resistance of Staphylococcus aureus to Bacteriophage. , 1953, Journal of General Microbiology.

[5]  J. Soothill Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. , 1994, Burns : journal of the International Society for Burn Injuries.

[6]  J. Morison Bacteriophage in the treatment and prevention of cholera , 1932 .

[7]  P. McCracken,et al.  Letter: Tennis elbow. , 1974 .

[8]  M. Dabrowski,et al.  Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. , 1987, Archivum immunologiae et therapiae experimentalis.

[9]  H. Smith,et al.  Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. , 1983, Journal of general microbiology.

[10]  R. T. Fisk Studies on StaphylococciI. Occurrence of Bacteriophage Carriers among Strains of Staphylococcus Aureus , 1942 .

[11]  A. Kucharewicz-Krukowska,et al.  Immunogenic effect of bacteriophage in patients subjected to phage therapy. , 1987, Archivum immunologiae et therapiae experimentalis.

[12]  K. M. Shaw,et al.  The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. , 1987, Journal of general microbiology.

[13]  H. Smith,et al.  Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. , 1982, Journal of general microbiology.

[14]  M. Lovell,et al.  Use of Lytic Bacteriophage for Control of Experimental Escherichia coli Septicemia and Meningitis in Chickens and Calves , 1998, Clinical Diagnostic Laboratory Immunology.

[15]  P. Barrow,et al.  The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. , 1991, Research in microbiology.

[16]  A. Afendra,et al.  Expression and stability of a recombinant plasmid in Zymomonas mobilis and Escherichia coli. , 1987, Journal of general microbiology.

[17]  P. Barrow,et al.  Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. , 1997, Trends in microbiology.

[18]  R. Dubos,et al.  THE MULTIPLICATION OF BACTERIOPHAGE IN VIVO AND ITS PROTECTIVE EFFECT AGAINST AN EXPERIMENTAL INFECTION WITH SHIGELLA DYSENTERIAE , 1943, The Journal of experimental medicine.